These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21594535)

  • 21. Significance of effector protease receptor-1 expression and its relationship with proliferation and apoptotic index in patients with primary advanced gastric adenocarcinoma.
    Yao XQ; Liu FK; Li JS; Qi XP; Wu B; Yin HL; Ma HH; Shi QL; Zhou XJ
    World J Gastroenterol; 2004 May; 10(9):1262-7. PubMed ID: 15112339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extent of spontaneous apoptosis in gastric cancer: relation to proliferative index, p53 expression, CD 34 expression and histopathological features.
    Jesionek-Kupnicka D; Tenderenda M; Rutkowski P
    J Exp Clin Cancer Res; 2002 Sep; 21(3):371-5. PubMed ID: 12385580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast.
    Gandhi A; Holland PA; Knox WF; Potten CS; Bundred NJ
    Br J Cancer; 1998 Sep; 78(6):788-94. PubMed ID: 9743302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of apoptosis status and apoptosis-associated antigen expression in human colorectal adenocarcinoma sequence].
    Li L; Yan L; Wei Y; Liu Z; Wang Z; Lei S; Huang G
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Jun; 30(2):185-7, 191. PubMed ID: 12212055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
    Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
    Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.
    Sierra A; Castellsagué X; Tórtola S; Escobedo A; Lloveras B; Peinado MA; Moreno A; Fabra A
    Clin Cancer Res; 1996 Nov; 2(11):1887-94. PubMed ID: 9816145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers.
    Zhang GJ; Kimijima I; Abe R; Watanabe T; Kanno M; Hara K; Tsuchiya A
    Anticancer Res; 1998; 18(3B):1989-98. PubMed ID: 9677455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
    Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC
    Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
    Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
    Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-induced apoptosis and p53, BCL-2 and BAX expression in breast cancer tissues in vivo and in fibroblast cells in vitro.
    Suzuki K; Kazui T; Yoshida M; Uno T; Kobayashi T; Kimura T; Yoshida T; Sugimura H
    Jpn J Clin Oncol; 1999 Jul; 29(7):323-31. PubMed ID: 10470656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation between apoptotic index, bcl-2 protein expression and progression and prognosis in breast carcinoma].
    Zhang GJ; Kimijima I; Watanabe T; Kanno M; Sagara H; Furukawa Y; Tsuchiya A; Abe R
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():415-21. PubMed ID: 9589045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
    Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
    Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
    King ED; Matteson J; Jacobs SC; Kyprianou N
    J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells.
    Clay CE; Namen AM; Atsumi G; Willingham MC; High KP; Kute TE; Trimboli AJ; Fonteh AN; Dawson PA; Chilton FH
    Carcinogenesis; 1999 Oct; 20(10):1905-11. PubMed ID: 10506103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. bcl-2 and apoptosis in lymph node positive breast carcinoma.
    Berardo MD; Elledge RM; de Moor C; Clark GM; Osborne CK; Allred DC
    Cancer; 1998 Apr; 82(7):1296-302. PubMed ID: 9529021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of bax and p53 proteins in the tumorigenesis and progression of breast carcinomas.
    Redondo M; Garcia J; Rodrigo I; Villar E; González C; Morell M
    Tumour Biol; 2003; 24(1):23-31. PubMed ID: 12743423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The search for optimal cutoff points for apoptosis and proliferation rate in prognostification of early stage breast cancer patients treated with anthracyclines in adjuvant settings.
    Biesaga B; Niemiec J; Wysocka J; Słonina D; Ziobro M
    Tumour Biol; 2016 Jun; 37(6):7645-55. PubMed ID: 26687650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
    Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R
    Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression.
    Tu H; Jacobs SC; Borkowski A; Kyprianou N
    Int J Cancer; 1996 Oct; 69(5):357-63. PubMed ID: 8900367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.